Publications


2022

Risk Assessment in Population-Based Breast Cancer Screening.

Eriksson M, Conant EF, Kontos D, Hall P.


JCO
202207
https://pubmed.ncbi.nlm.nih.gov/35452252/

Time to Mammographic Density Decrease After Exposure to Tamoxifen

Magnus Bäcklund, Mikael Eriksson, Mattias Hammarström, Linda Thoren, Jenny Bergqvist, Sara Margolin, Roxanna Hellgren, Yvonne Wengström, Marike Gabrielson, Kamila Czene, Per Hall.


Oncologist
202207
https://pubmed.ncbi.nlm.nih.gov/35605013/

Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention.

Moorthie S, Babb de Villiers C, Burton H, Kroese M, Antoniou AC, Bhattacharjee P, Garcia-Closas M, Hall P, Schmidt MK.


Prev Med
202206
https://pubmed.ncbi.nlm.nih.gov/35526672/

A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care.

Eriksson M, Destounis S, Czene K, Zeiberg A, Day R, Conant EF, Schilling K, Hall P.


Sci Transl Med
202205
https://pubmed.ncbi.nlm.nih.gov/35544593/

Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.

Strandberg R, Czene K, Eriksson M, Hall P, Humphreys K.


Cancer Epidemiol Biomarkers
202203
https://pubmed.ncbi.nlm.nih.gov/35027432/

Risk of heart disease following treatment for breast cancer – results from a population-based cohort study.

Yang H, Bhoo-Pathy N, Brand JS, Hedayati E, Grassmann F, Zeng E, Bergh J, Bian W, Ludvigsson JF, Hall P, Czene K.


Elife
202203
https://pubmed.ncbi.nlm.nih.gov/35293856/

Interval breast cancer is associated with interferon immune response.

Ugalde-Morales E, Grassmann F, Humphreys K, Li J, Eriksson M, Tobin NP, Lindström LS, Vallon-Christersson J, Borg Å, Hall P, Czene K.


Eur J Cancer
202202
https://pubmed.ncbi.nlm.nih.gov/35026490/

Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer.

Thomas CE, Dahl L, Byström S, Chen Y, Uhlén M, Mälarstig A, Czene K, Hall P, Schwenk JM, Gabrielson M.


Transl Oncol
202201
https://pubmed.ncbi.nlm.nih.gov/35033985/

2021

[It is time for individual breast cancer prevention].

Hall P, Hammarström M, Hellgren R.


Läkartidningen
202109
https://pubmed.ncbi.nlm.nih.gov/34498240/

Mammographic features are associated with cardiometabolic disease risk and mortality.

Grassmann F, Yang H, Eriksson M, Azam S, Hall P, Czene K.


Eur Heart J
202109
https://pubmed.ncbi.nlm.nih.gov/34338750/

Mammographic microcalcifications and risk of breast cancer.

Azam S, Eriksson M, Sjölander A, Gabrielson M, Hellgren R, Czene K, Hall P.


Br J Cancer
202108
https://pubmed.ncbi.nlm.nih.gov/34127810/

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial

W He, M Eriksson, E Eliasson, F Grassmann, M Bäcklund, M Gabrielson, M Hammarström, S Margolin, L Thorén, Y Wengström, S Borgquist, P Hall, K Czene.


Annals of Oncology
202107
https://pubmed.ncbi.nlm.nih.gov/34284099/

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.

Eriksson M, Eklund M, Borgquist S, Hellgren R, Margolin S, Thoren L, Rosendahl A, Lång K, Tapia J, Bäcklund M, Discacciati A, Crippa A, Gabrielson M, Hammarström M, Wengström Y, Czene K, Hall P.


J Clin Oncol.
202103
https://pubmed.ncbi.nlm.nih.gov/33734864

Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses.

Ong JS, Derks EM, Eriksson M, An J, Hwang LD, Easton DF, Pharoah PP, Berchuck A, Kelemen LE, Matsuo K, Chenevix-Trench G, Hall P, Bojesen SE, Webb PM, MacGregor S.


Int J Cancer
202103
https://pubmed.ncbi.nlm.nih.gov/32976626/

Breast Cancer Risk Genes – Association Analysis in More than 113,000 Women.

Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, et al.


N Engl J Med.
202101
https://pubmed.ncbi.nlm.nih.gov/33471991

Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women.

Eriksson M, Czene K, Conant EF, Hall P.


Cancers (Basel).
202101
https://pubmed.ncbi.nlm.nih.gov/33467653

2020

Sense of coherence and risk of breast cancer.

Hu K, Eriksson M, Wengström Y, Czene K, Hall P, Fang F.


Elife.
202011
https://pubmed.ncbi.nlm.nih.gov/33226344

Concordance of Immunohistochemistry-Based and Gene Expression-Based Subtyping in Breast Cancer.

Holm J, Yu NY, Johansson A, Ploner A, Hall P, Lindström LS, Czene K.


JNCI Cancer Spect
202010
https://pubmed.ncbi.nlm.nih.gov/33442660/

Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics: A population-based cohort study.

Tan PS, Ali MA, Eriksson M, Hall P, Humphreys K, Czene K.


Int J Cancer.
202009
https://pubmed.ncbi.nlm.nih.gov/32976625

Predictors of mammographic microcalcifications.

Azam S, Eriksson M, Sjölander A, Gabrielson M, Hellgren R, Czene K, Hall P.


Int J Cancer.
202009
https://pubmed.ncbi.nlm.nih.gov/32949149